Clinical Trials Browser

Phase 1 × eribulin × Gastrointestinal × Clear all

NCT06328738 2025-11-19

ELVN-002 With Trastuzumab +/- Chemotherapy in HER2+ Solid Tumors, Colorectal and Breast Cancer

Phase 1 Active not recruiting

Gastrointestinal

Colorectal Neoplasms